Evidence map›Paper›PMID 26247005›Full record

ArticleClinical and translational imaging2014

The role of PET quantification in cardiovascular imaging.

Piotr Slomka, Daniel S Berman, Erick Alexanderson, Guido Germano

Open access · bronzeAbstract read
In one paragraph

Article in Clinical and translational imaging, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Myocardial perfusion imaging in advanced coronary artery disease.European journal of clinical investigation · 2025
    Review
  6. Review
  7. Article
  8. Review
  9. EJNMMI physics · 2025
    Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Hot spot imaging in cardiovascular diseases: an information statement from SNMMI, ASNC, and EANM.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Piotr SlomkaDepartments of Imaging and Medicine, and Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA ; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA.
Daniel S BermanDepartments of Imaging and Medicine, and Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA.
Erick AlexandersonCardiovascular Imaging & Nuclear Cardiology Department, Instituto Nacional de Cardiología 'Ignacio Chávez', Mexico City, Mexico ; Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Guido GermanoDepartments of Imaging and Medicine, and Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA ; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA.
Cedars-Sinai Medical Center · USInstituto Nacional de Cardiología · MXUniversity of California, Los Angeles · US

Funding

Quantitative Prediction of Disease and Outcomes from Next Generation SPECT and CTR01HL089765 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI SLOMKA, PIOTR J · 2007 to 2021
$6.1M
NHLBI NIH HHS R01 HL089765
6 · The paper itself

Abstract

Positron Emission Tomography (PET) has several clinical and research applications in cardiovascular imaging. Myocardial perfusion imaging with PET allows accurate global and regional measurements of myocardial perfusion, myocardial blood flow and function at stress and rest in one exam. Simultaneous assessment of function and perfusion by PET with quantitative software is currently the routine practice. Combination of ejection fraction reserve with perfusion information may improve the identification of severe disease. The myocardial viability can be estimated by quantitative comparison of fluorodeoxyglucose (

Indexed as

cardiac functioncardiac PETcoronary flow reservehybrid PET/CTmyocardial perfusionmyocardial perfusion flowmyocardial viabilityquantificationvascular imagingvulnerable plaque

Identifiers

PMID26247005
PMCPMC4523308
OpenAlexW2044675804

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.